If you want to monitor your vital signs like an Olympic athlete, you should welcome a pact between glucose-monitor vendor ...

I'm Ryan Weispfenning, vice president and head of Medtronic investor relations, and I appreciate that you're joining us for ...

Wearable diagnostics are poised to transform subjective, episodic measures of disease progression to quantified, continuous data streams, according to some industry experts.

Dexcom (Nasdaq:DXCM) announced today that it entered into a strategic partnership with Oura, maker of leading smart ring ...

Diabetes care device developer Dexcom and ŌURA, maker of the Oura smart ring, have announced a strategic partnership that aim ...

DexCom invests $75M in Finnish health tech firm ŌURA, forming a strategic partnership to integrate glucose data with vital signs and biometrics.

As part of this integration, consumers who use both Dexcom glucose biosensors, including its over-the-counter product Stelo, ...

Medical device maker Dexcom said on Tuesday it will invest $75 million in Ōura's latest funding round, valuing the smart ring maker at over $5 billion.